Search results
How Quickly Does Farxiga Create Weight Loss?
Verywell Health via Yahoo News· 7 months agoFarxiga (dapagliflozin) is an orally administered, brand-name medication classified as a sodium-glucose co-transporter 2 (SGLT2) inhibitor. SGLT2...
US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy
Reuters via Yahoo News· 7 months ago(Reuters) -Some leading U.S. obesity specialists say they expect Eli Lilly’s powerful weight-loss...
The battle for weight loss drug dominance is heating up. Here's why.
Yahoo Finance via AOL· 7 months agoThe race to grab market share of the booming obesity drug market has officially begun, with...
Game changers for diabetics
The Ledger via Yahoo News· 2 years agoGLP-1 Agonists and SGLT-2 Inhibitors May Be Game Changers for Diabetics By Robin Williams Adams Your Health Correspondent More than 50 brands of...
Ozempic, Mounjaro and hundreds of other drugs become even more expensive in 2024
CNN Business via Yahoo Finance· 4 months agoSome Americans may have to shell out more this year for Ozempic and Mounjaro, two wildly popular...
Pharma companies raise prices on over 900 drugs amid 'historic' negotiations
USA TODAY via Yahoo News· 4 months agoAs the federal government seeks to rein in drug prices, pharmaceutical companies this year have been...
Move Aside, Eli Lilly and Novo Nordisk. Wall Street Thinks This Stock Will Be a Bigger Winner Over...
Motley Fool via Yahoo Finance· 4 months agoWeight-loss drugs are hot. Just look at the recent performances of Eli Lilly (NYSE: LLY), which won...
AstraZeneca Is Making A $2 Billion Bet To Rival Lilly, Novo In Obesity Drugs
Investor's Business Daily· 7 months agoShares of AZN stock popped Thursday after AstraZeneca said it would spend up to $2.01 billion to...
Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca
Zacks via Yahoo Finance· 10 months agoFor Immediate Release Chicago, IL – August 22, 2023 – Today, Zacks Equity Research discusses Eli...
Pre-diabetes rates increase amidst a renaissance for type 2 diabetes research
Pharmaceutical Technology via Yahoo Finance· 5 days agoEngland’s National Health Service (NHS) has reported an 18% increase in the number of people with...
